Home » Topics » Regulatory » Patents

Patents
RSS

ChemoCentryx divulges new chemokine CCR1 receptor antagonists for immune disorders

Jan. 8, 2009

New angiotensin II AT1 receptor antagonists developed by Eldrug researchers

Jan. 7, 2009

Novel mutilin derivatives with antibacterial activity reported in recent Kyorin patent

Jan. 7, 2009

Mpex Pharmaceuticals patent discloses novel bacterial efflux pump inhibitors

Jan. 7, 2009

New mgluR2 ligands/5-HT2A antagonists described in Abbott patent

Jan. 5, 2009

New chymase inhibitors for cardiovascular diseases patented at Boehringer Ingelheim

Jan. 5, 2009

Novel matrix metalloproteinase inhibitors from Array BioPharma

Jan. 5, 2009

Dr. Reddy's patents novel antibacterial agents

Dec. 31, 2008

TorreyPines describes new agents for Alzheimer's disease in recent patent

Dec. 31, 2008

Recent patents impart novel anticancer agents

Dec. 31, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...